Manufacturer record
Lark Laboratories (India) Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Lark Laboratories (India) Ltd (Rajasthan) were declared Not of Standard Quality between February 2019 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Lark Laboratories (India) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Valsartan Tablets IP 80mg(Valsalar- 80 Tablets) | VSR1-05Mfg 2024-04 · Exp 2026-03 | The Sample does not conform to IP Standards with respect to Test for Dissolution onlyDissolution | CDTL ChennaiCDSCO lab | Dec 2024 |
| Symolar-Forte | SFT5-61Mfg 2024-04 · Exp 2025-09 | sample does not conform to Schedule V of D&C Act with respect to general requirement for tabletsOther | DTL ChennaiState lab | Nov 2024 |
| Betamethasone Sodium Phosphate Tablets I.P. (Betalar-S) | BT3-50Mfg 2023-12 · Exp 2025-11 | DescriptionDescription | CDL KolkataCDSCO lab | Mar 2024 |
| PARACETAMOL TABLETS IP (Larkin) | E-23Mfg 2021-12 · Exp 2024-11 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Paracetamol Tablets I.P. (LARKIN) | E-10Mfg 2017-08 · Exp 2019-07 | DissolutionDissolution | Drugs Control Department, MizoramCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.